Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore a comprehensive medical lecture where Dr. Shonali Midha from Dana-Farber Cancer Institute examines the emerging role and therapeutic potential of bispecific antibodies in treating relapsed/refractory multiple myeloma, providing valuable insights into this innovative treatment approach for healthcare professionals and researchers in the field of hematologic oncology.
